DuPont is proud to be part of the 4th Microbiome Movement – Drug Development Europe 2020, which returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.
Do not miss the opportunity to hear, Sebastien Guery, Human Microbiome Venture Leader, DuPont Nutrition & Biosciences who will take part in a Panel Discussion: How can Start-Ups Raise Capital to Accelerate Microbiome- Focused Drug Platforms? and a Panel Discussion: The Borderline Between Pharma and Food – How is the Microbiome Blurring the Lines? on February 6.
Register to take part: https://microbiome-europe.com/take-part/register/